FORT WORTH, Texas--(BUSINESS WIRE)--April 25, 2005--Alcon, Inc., (NYSE:ACL) announced the launch of the AcrySof(R) ReSTOR(R) Intraocular Lens (IOL) at a press conference during the American Society of ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. SAN DIEGO — Bilateral implantation of an apodized ...
Slit lamp photo of the ReStor IOL in the eye. (All images courtesy of Francesco Carones, MD.) BARCELONA – The apodized optic design of the pseudoaccomodative Alcon AcrySof ReStor IOL may overcome the ...
The unique optical design of the ACTIVEFOCUS (TM) toric IOL gives astigmatic cataract patients quality distance vision and an increased range of vision to potentially reduce dependence on glasses This ...
April 15, 2005 — The U.S. Food and Drug Administration (FDA) has approved a rechargeable neurostimulation system to aid in the management of chronic intractable pain of the trunk and/or limbs; a dural ...
Basel, Switzerland, April 16, 2015-Alcon, the global leader in eye care and a division of Novartis, has received approval from the US Food and Drug Administration (FDA) for its AcrySof ® IQ ReSTOR ® ...
Oct. 27, 2004 (New Orleans) — New data from a European trial of the AcrySof ReSTOR MA60D3 intraocular lens (IOL) shows that overall 74% of bilateral cataract patients did not use glasses for near or ...
GAITHERSBURG, Maryland — The ophthalmic devices advisory committee voted 12-0 that the benefits of the Acrysof IQ ReSTOR intraocular lens made by Alcon (Fort Worth, Texas), outweigh the risks, thus ...
For years, patients who underwent cataract surgery had to wear glasses or contact lenses afterwards to see clearly. The newly developed ReSTOR® lens has overcome this problem, allowing patients to see ...
Here is the current list (as of Feb. 9, 2011) of posterior chamber (P-C) and anterior chamber (A-C) intraocular lenses recognized by CMS. – Crystalens, manufactured by Eyeonics (now Bausch & Lomb). – ...
Basel, March 23, 2017 - Alcon, the global leader in eye care and a division of Novartis, has received approval from the US Food and Drug Administration (FDA) for its AcrySof® IQ ReSTOR® +2.5 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results